Deferred Tax Assets, Valuation Allowance of Solid Biosciences Inc. from 31 Mar 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Solid Biosciences Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2018 to 31 Dec 2024.
  • Solid Biosciences Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $130,690,000, a 43% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Solid Biosciences Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $130,690,000 +$38,985,000 +43% 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q4 2023 $91,705,000 -$71,861,000 -44% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $163,566,000 +$34,996,000 +27% 31 Dec 2022 10-K 06 Mar 2025 2024 FY
Q4 2021 $128,570,000 +$27,830,000 +28% 31 Dec 2021 10-K 13 Mar 2024 2023 FY
Q4 2020 $100,740,000 +$31,569,000 +46% 31 Dec 2020 10-K 23 Mar 2023 2022 FY
Q4 2019 $69,171,000 +$43,917,000 +174% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q4 2018 $25,254,000 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 $16,657,000 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 $10,008,000 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 $3,285,000 31 Mar 2018 10-Q 10 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.